z-logo
open-access-imgOpen Access
Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus.
Author(s) -
Giovanni Mazzotti,
Nicoletta Zini,
E Rizzi,
R. Rizzoli,
A. Galanzi,
Andrea Ognibene,
Spartaco Santi,
Alessandro Matteucci,
Alberto M. Martelli,
N. M. Maraldi
Publication year - 1995
Publication title -
journal of histochemistry and cytochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 124
eISSN - 1551-5044
pISSN - 0022-1554
DOI - 10.1177/43.2.7822774
Subject(s) - immunolabeling , phosphatidylinositol 4,5 bisphosphate , second messenger system , nucleus , phosphatidylinositol , nuclear matrix , microbiology and biotechnology , immunocytochemistry , cytoplasm , nuclear localization sequence , inner membrane , cytoskeleton , chemistry , diacylglycerol kinase , signal transduction , biology , biochemistry , cell , immunohistochemistry , mitochondrion , protein kinase c , immunology , dna , endocrinology , chromatin
Phosphatidylinositol 4,5-bisphosphate (PIP2) is a key element of signal transduction, being the preferential substrate of specific phospholipases that produce second messengers such as inositol trisphosphate (IP3) and diacylglycerol (DG). Because PIP2 has been cytochemically identified by monoclonal antibodies not only in the cytoplasmic membranes but also in the nuclear envelope and within the nucleus, we performed a study by immunoblotting and by confocal and electron microscopic immunocytochemistry to identify the nuclear sites of PIP2 localization and to exclude any cross-reactivity of the antibody with other nuclear molecules. The results confirm the specificity of the immunolabeling and indicate that PIP2 is localized at precise intranuclear sites both in in situ and in isolated nuclei. They also show that a significant amount of the phospholipid is retained by the cytoskeleton and by the inner nuclear matrix in in situ matrix preparations. Moreover the sensitivity of the immunocytochemical reaction is capable of detecting quantitative variations of PIP2 nuclear content induced by agonists that modulate the signal transduction system at the nuclear level.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom